The management of congenital and acquired neutropenias presents some differences according to the type of the disease. Treatment with recombinant human granulocyte-colony stimulating factor (G-CSF) is not standardized and scanty data are available on the best schedule to apply. The frequency and the type of longitudinal controls in patients affected with neutropenias are not usually discussed in the literature. The Neutropenia Committee of the Marrow Failure Syndrome Group (MFSG) of the Associazione Italiana di Emato-Oncologia Pediatrica (AIEOP) elaborated this document following design and methodology formerly approved by the AIEOP board. The panel of experts reviewed the literature on the topic and participated in a conference producing a document that includes recommendations on neutropenia treatment and timing of follow-up. © 2011 Wiley Periodicals, Inc.

Fioredda, F., Calvillo, M., Bonanomi, S., Coliva, T., Tucci, F., Farruggia, P., et al. (2012). Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). AMERICAN JOURNAL OF HEMATOLOGY, 87(2), 238-243 [10.1002/ajh.22242].

Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica)

COLIVA, TIZIANA ANGELA;
2012

Abstract

The management of congenital and acquired neutropenias presents some differences according to the type of the disease. Treatment with recombinant human granulocyte-colony stimulating factor (G-CSF) is not standardized and scanty data are available on the best schedule to apply. The frequency and the type of longitudinal controls in patients affected with neutropenias are not usually discussed in the literature. The Neutropenia Committee of the Marrow Failure Syndrome Group (MFSG) of the Associazione Italiana di Emato-Oncologia Pediatrica (AIEOP) elaborated this document following design and methodology formerly approved by the AIEOP board. The panel of experts reviewed the literature on the topic and participated in a conference producing a document that includes recommendations on neutropenia treatment and timing of follow-up. © 2011 Wiley Periodicals, Inc.
Articolo in rivista - Articolo scientifico
Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Consensus; Disease Management; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Neutropenia; Transplantation, Autologous; Transplantation, Homologous; Bone Marrow Transplantation; Hematology
English
2012
87
2
238
243
none
Fioredda, F., Calvillo, M., Bonanomi, S., Coliva, T., Tucci, F., Farruggia, P., et al. (2012). Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). AMERICAN JOURNAL OF HEMATOLOGY, 87(2), 238-243 [10.1002/ajh.22242].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/67281
Citazioni
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 38
Social impact